Filter Results
:
(951)
Show Results For
-
All HBS Web
(2,464)
- Faculty Publications (951)
Show Results For
-
All HBS Web
(2,464)
- Faculty Publications (951)
- 1992
- Book
Creating New Health Care Ventures: The Role of Management
By: R. E. Herzlinger
Herzlinger, R. E. Creating New Health Care Ventures: The Role of Management. Gaithersburg, MD: Aspen Publishing, 1992.
- June 1992
- Teaching Note
Visiting Nurse Service of New York, Teaching Note
- May 1992
- Teaching Note
Hospital Corp. of America and McLean Hospital, Teaching Note
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S....
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Ethics;
Business and Government Relations;
Communication Strategy;
Health Care and Treatment;
Monopoly;
Intellectual Property;
Research and Development;
Price;
Pharmaceutical Industry;
London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)
- March 1990 (Revised March 1992)
- Case
New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign
By: V. Kasturi Rangan and Sohel Karim
Describes the background leading to the development of an advertising campaign to help prevention of AIDS in New York City. The three television networks, however, for various reasons reject the campaign, to the dismay of Saatchi & Saatchi executives.
View Details
Keywords:
Advertising Campaigns;
Growth and Development;
Health Care and Treatment;
Marketing Communications;
Failure;
Advertising Industry;
New York (city, NY)
Rangan, V. Kasturi, and Sohel Karim. "New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign." Harvard Business School Case 590-036, March 1990. (Revised March 1992.)
- 1990
- Chapter
Analysis of Cost Variances for Management Control in Hospitals
By: S. Datar, R. Banker and S. Das
- April 1989 (Revised January 1994)
- Case
Novo Industri
By: Michael E. Porter and Michael J. Enright
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an...
View Details
Keywords:
Change;
Global Strategy;
Industry Structures;
Alliances;
Competitive Strategy;
Health Disorders;
Pharmaceutical Industry
Porter, Michael E., and Michael J. Enright. "Novo Industri." Harvard Business School Case 389-148, April 1989. (Revised January 1994.)
- April 1989 (Revised May 1993)
- Case
Novel Combination of Two Drugs (A)
Herzlinger, Regina E. "Novel Combination of Two Drugs (A)." Harvard Business School Case 189-168, April 1989. (Revised May 1993.)
- April 1989
- Supplement
Novel Combination of Two Drugs (B)
Herzlinger, Regina E. "Novel Combination of Two Drugs (B)." Harvard Business School Supplement 189-169, April 1989.
- April 1989
- Supplement
Novel Combination of Two Drugs (C)
Herzlinger, Regina E. "Novel Combination of Two Drugs (C)." Harvard Business School Supplement 189-170, April 1989.
- 01 Jan 1986
- Conference Presentation
Design of a Management Support System for Hospital Strategic Planning
By: L. M. Applegate, R. O. Mason and D. Thorpe
- February 1985 (Revised January 2024)
- Case
Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment
By: Regina E. Herzlinger, Joyce Lallman, Nancy Kane, Jefferson C. Grahling and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating In Health Care course book.
This note and case series enables readers to conduct...
View Details
Keywords:
For-Profit Firms;
Business Model;
Entrepreneurship;
Health Care and Treatment;
Strategy;
Valuation;
Health Industry;
Retail Industry
Herzlinger, Regina E., Joyce Lallman, Nancy Kane, Jefferson C. Grahling, and James Wallace. "Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment." Harvard Business School Case 185-084, February 1985. (Revised January 2024.)
- September 1983 (Revised July 1991)
- Case
Orthoteks USA (A)
A series on implementing strategy as the head of the U.S. subsidiary of a successful Swiss medical products firm. Traces the actions of the CEO over a four year period and highlights his negotiations with the Swiss parent and the way functional components of the...
View Details
Keywords:
Business Subsidiaries;
Trade;
Health Care and Treatment;
Leadership Style;
Agreements and Arrangements;
Strategy;
Health Industry;
Switzerland;
United States
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "Orthoteks USA (A)." Harvard Business School Case 384-057, September 1983. (Revised July 1991.)
- April 1983 (Revised June 2003)
- Case
Shouldice Hospital Limited
By: James L. Heskett
Various proposals are set forth for expanding the capacity of the hospital. In assessing them, serious consideration has to be given to the culture of the organization and the importance of preserving it in a service delivery system. In addition to issues of capacity...
View Details
Keywords:
Expansion;
Health Care and Treatment;
Performance Capacity;
Organizational Culture;
Service Delivery;
Growth Management;
Strategic Planning;
Quality;
Social Enterprise;
Health Industry;
Canada
Heskett, James L. "Shouldice Hospital Limited." Harvard Business School Case 683-068, April 1983. (Revised June 2003.)
- January 1983 (Revised February 1988)
- Case
Hospital Corp. of America (A)
By: W. Carl Kester
HCAs ratio of debt to total capital is approaching 70%, jeopardizing its single-A bond rating. Students must determine an appropriate target debt ratio for HCA in light of its growth objectives, its acquisition strategy and its changing regulatory environment.
View Details
Keywords:
Situation or Environment;
Capital Structure;
Health Care and Treatment;
Borrowing and Debt;
Health Industry;
Tennessee
Kester, W. Carl. "Hospital Corp. of America (A)." Harvard Business School Case 283-053, January 1983. (Revised February 1988.)
- October 1982 (Revised May 1992)
- Case
Johnson & Johnson: The Tylenol Tragedy
In October 1982, Johnson & Johnson was confronted with a major crisis when seven deaths were attributed to poisoned Tylenol. The case reviews the facts as known a week after the incident occurred, and raises a wide range of questions regarding consumer behavior,...
View Details
Keywords:
Consumer Behavior;
Corporate Social Responsibility and Impact;
Competitive Strategy;
Crisis Management;
Health Care and Treatment;
Pharmaceutical Industry
Greyser, Stephen A. "Johnson & Johnson: The Tylenol Tragedy." Harvard Business School Case 583-043, October 1982. (Revised May 1992.)
- 1980
- Working Paper
Components of Manufacturing Inventories: A Structural Model of the Production Process
By: Alan J. Auerbach and Jerry R. Green
This paper presents a structural model of production and inventory accumulation based on the hypothesis of cost minimization. It differs from previous attempts in several respects. First, it integrates the analysis of input inventories with output inventories, treating...
View Details
Auerbach, Alan J., and Jerry R. Green. "Components of Manufacturing Inventories: A Structural Model of the Production Process." NBER Working Paper Series, No. 491, June 1980.
- 1977
- Chapter
Cost Benefit Analysis of Surgery: Some Additional Caveats and Interpretation
By: Jerry R. Green
Green, Jerry R. "Cost Benefit Analysis of Surgery: Some Additional Caveats and Interpretation." In Costs, Risks and Benefits of Surgery, edited by J. Bunker, B. Barnes, and F. Mosteller. New York: Oxford University Press, 1977.